HEALEY ALS Platform Trial REGIMEN-SPECIFIC APPENDIX [I] FOR NUZ-001
The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS. Regimen I will evaluate the safety and efficacy of a single study drug, NUZ-001, in participants with ALS.
Study ID: 4827
NCT Number: NCT07410806
Principal Investigator: Vovanti Jones, MD
Department: Physical Medicine & Rehab
Eligibility: Both men and women 18 years old to 100 years old. Accepts healthy volunteers.
For questions about this study, please contact:
ClinicalTrialsInterest@health.missouri.edu(573) 882-7026